Home » Newsletters » BioWorld Science

BioWorld Science

April 8, 2014

View Archived Issues

Clinical study evaluates immunological response EMD-640744 in solid tumors

Shandong Xuanzhu Pharmaceutical Technology patents novel inhibitors for cancer

Mitsubishi Tanabe Pharma discloses new TRPM8 agonists for chronic pain

Meda and Valeant terminate joint ventures in Canada, Mexico and Australia

Santen and Oak Pharmaceuticals sign U.S. tafluprost licensing agreement

Pharmacokinetic bioequivalence of biosimilar GP-2017 and reference adalimumab

Lilly and Deciphera Pharmaceuticals present data on LY-3009120

Aptiom launched in the U.S. for use as adjunctive treatment of partial-onset seizures

Novel dendrimer-drug conjugates patented by Indian university

Mersana Therapeutics and Takeda to develop next-generation antibody-drug conjugates

IGM-55.5 potently binds and kills B cells in NHL patients

Soligenix receives SBIR grant award supporting phase II trial of SGX-942

JNJ-61186372 demonstrates activity for the treatment EGFR/c-Met-aberrant malignancies

Genentech and Array BioPharma reports ERK-1/2 inhibitor, GDC-0994

Abbott and AbbVie disclose new PDE10A inhibitors

Roche and Oryzon to develop epigenetics-based medicines

Pradaxa approved for deep venous thrombosis and pulmonary embolism

Merck & Co., Ferring and WHO to study room temperature-stable carbetocin for post-partum hemorrhage

Daiichi Sankyo extends European PREFER in AF registry

Cancer Genetics launches CALR mutation analysis test

Arno Therapeutics enrolls first patient in phase I/II onapristone trial in prostate cancer

Bristol-Myers Squibb submits daclatasvir and asunaprevir NDAs to FDA for HCV

Sun Pharmaceutical to acquire Ranbaxy Laboratories from Daiichi Sankyo

RedHill Biopharma to submit European MAA for RHB-102

Xenetic Biosciences reports phase I data for PulmoXen in cystic fibrosis

OncoSec Medical to relaunch phase II CTCL trial of ImmunoPulse DNA IL-12

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...